Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LQR House | LQR | Nov 14, 2024 | 0.90 | +8.26 |
LSB Industries | LXU | Nov 14, 2024 | 8.48 | -2.86 |
LSI Industries | LYTS | Nov 14, 2024 | 20.45 | -0.24 |
Ltc Properties | LTC | Nov 14, 2024 | 38.16 | -1.14 |
Lucas GC | LGCL | Nov 14, 2024 | 1.18 | +0.85 |
Lucid Diagnostics | LUCD | Nov 14, 2024 | 1.01 | -3.81 |
Lucid Group | LCID | Nov 14, 2024 | 2.08 | -4.59 |
Lufax ADR | LU | Nov 14, 2024 | 2.33 | -3.32 |
Lululemon Athletica | LULU | Nov 14, 2024 | 330.26 | +0.60 |
Lulus Fashion Lounge | LVLU | Nov 14, 2024 | 1.42 | -12.11 |
Lumen Technologies | LUMN | Nov 14, 2024 | 8.63 | -2.92 |
Lument Finance Trust | LFT | Nov 14, 2024 | 2.46 | +3.36 |
Lument Finance Trust A Pref | LFT-A | Nov 14, 2024 | 23.15 | +0.13 |
Lumentum | LITE | Nov 14, 2024 | 85.13 | -3.33 |
Luminar Technologies A | LAZR | Nov 14, 2024 | 1.03 | -1.90 |
Lumos Pharma | LUMO | Nov 14, 2024 | 4.33 | +0.70 |
Luna Innovations | LUNA | Nov 14, 2024 | 1.57 | -3.68 |
Luokung Technology | LKCO | Nov 14, 2024 | 1.66 | -1.78 |
Luxfer | LXFR | Nov 14, 2024 | 14.65 | -1.61 |
LuxUrban Hotels | LUXH | Nov 14, 2024 | 0.04 | +6.25 |
Luxurban Hotels Pref | LUXHP | Nov 14, 2024 | 16.00 | -2.62 |
Lxp Industrial Trust | LXP | Nov 14, 2024 | 9.26 | -2.83 |
LXP Industrial Trust C Pref | LXP-C | Nov 14, 2024 | 50.21 | -1.70 |
Lyell Immunopharma | LYEL | Nov 14, 2024 | 1.10 | 0.00 |
Lyft A | LYFT | Nov 14, 2024 | 17.92 | +0.79 |
LyondellBasell Industries Nv A | LYB | Nov 14, 2024 | 82.56 | -1.05 |
Lyra Therapeutics | LYRA | Nov 14, 2024 | 0.18 | -8.95 |
Lytus Technologies | LYT | Nov 14, 2024 | 1.78 | -7.77 |
M&T Bank | MTB | Nov 14, 2024 | 213.27 | +0.63 |
M&T Bank ADR Prej J | MTB-J | Nov 14, 2024 | 27.48 | -0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.